Myelofibrosis with myeloid metaplasia (MMM) in young individuals: Disease characteristics, prognostic factors and identification of risk groups

被引：0
|
作者：
Cervantes, F
Barosi, G
Demory, JL
Reilly, J
Guarnone, R
Dupriez, B
Pereira, A
Montserrat, E
机构：
[1] Hosp Clin Clin, Dept Hematol, Barcelona, Spain
[2] IRCCS, Policlin San Matteo, Lab Med Informat, Pavia, Italy
[3] CHRU, Serv Malad Sang, Lille, France
[4] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [1] Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups
    Cervantes, F
    Barosi, G
    Demory, JL
    Reilly, J
    Guarnone, R
    Dupriez, B
    Pereira, A
    Montserrat, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) : 684 - 690
  • [2] Risk factors for elastic transformation in myelofibrosis with myeloid metaplasia (MMM).
    Barosi, G
    Quaglini, S
    Petti, C
    Grossi, A
    Pogliani, E
    Leoni, P
    Rotoli, B
    Finelli, C
    Foa, P
    Ambrosetti, A
    Rodeghiero, F
    Centra, A
    Guarnone, R
    Liberato, NL
    BLOOD, 1995, 86 (10) : 3147 - 3147
  • [3] Myelofibrosis with myeloid metaplasia: Diagnosis, prognostic factors, and staging
    Cervantes, F
    Barosi, G
    SEMINARS IN ONCOLOGY, 2005, 32 (04) : 395 - 402
  • [4] Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: an update anno 2000
    Cervantes, F
    PATHOLOGIE BIOLOGIE, 2001, 49 (02): : 148 - 152
  • [5] RISK FACTORS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA
    Baurmann, H.
    Collenbusch, F.
    Schmid, C.
    Finke, J.
    Stadler, M.
    Borubaeuser, M.
    Schleuning, M.
    Schwerdtfeger, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 3 - 3
  • [6] Leukemogenic risk of hydroxyurea (HU) therapy in polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM).
    Nand, S
    Stock, W
    Godwin, J
    Fisher, S
    BLOOD, 1995, 86 (10) : 3181 - 3181
  • [7] Prognostic factors and risk groups in idiopathic myelofibrosis: A study in a series of 106 patients
    Cervantes, F
    Pereira, A
    Esteve, J
    Rafel, M
    Rozman, C
    Montserrat, E
    BLOOD, 1996, 88 (10) : 2319 - 2319
  • [8] Separating patients with myelofibrosis with myeloid metaplasia into risk groups for allogeneic haematopoietic cell transplantation - results of a German multicentre analysis
    Collenbusch, F.
    Schwerdtfeger, R.
    Schleuning, M.
    Schmid, C.
    Finke, J.
    Stadler, M.
    Bornhaeuser, M.
    Messerer-Schmid, D.
    Baurmann, H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S52 - S53
  • [9] Disease characteristics and natural history of myelofibrosis with myeloid metaplasia in adults 30 year-old or younger.
    Cervantes, F
    Barosi, G
    Hernández-Boluda, JC
    Montserrat, E
    BLOOD, 2000, 96 (11) : 746A - 747A
  • [10] Identification of prognostic factors determining risk groups for lung resection
    Bernard, A
    Ferrand, L
    Hagry, O
    Benoit, L
    Cheynel, N
    Favre, JP
    ANNALS OF THORACIC SURGERY, 2000, 70 (04): : 1161 - 1167
12345